COMPOUNDS WHICH SPECIFICALLY BIND TO CD38 FOR USE IN THE TREATMENT OF NEURODEGENERATIVE AND INFLAMMATORY DISEASES
申请人:ENCEFA
公开号:US20210087290A1
公开(公告)日:2021-03-25
A compound, which specifically binds to CD38, for use as a medicament in the prevention and/or treatment of a neurodegenerative disease and/or an inflammatory disease, by the opening of NAADP receptors Two Pore Channels TPC1 and/or TPC2, wherein the compound activates the opening of NAADP receptors Two Pore Channels TPC1 and/or TPC2.